Nacto Pharma Limited
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of progressive breast cancer in postmenopausal women (in combination with exemestane), unresectable or metastatic neuroendocrine tumors of the pancreas, gastrointestinal tract, or lungs, as well as for the treatment of advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 10 mg ATC: L01XE10
-
The drug is used for the treatment of progressive breast cancer in postmenopausal women (in combination with exemestane), unresectable or metastatic neuroendocrine tumors of the pancreas, gastrointestinal tract, or lungs, as well as for the treatment of advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 5 mg ATC: L01XE10
-
The drug is intended for adults and children aged 1 year and older for the treatment of influenza symptoms, as well as for the prevention of influenza after contact with an infected person or during a seasonal epidemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir 30 mg ATC: J05AH02
-
The drug is intended for the treatment and prevention of influenza in adults and children aged 1 year and older. It should be used during the circulation of the influenza virus.
Dosage form: capsules, hard
Active substance Dosage oseltamivir 45 mg ATC: J05AH02
-
Natflu is prescribed for adults and children from 1 year of age to treat flu symptoms, as well as for the prevention of influenza after contact with an infected person or during a seasonal epidemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir 75 mg ATC: J05AH02
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with bortezomib and dexamethasone or with dexamethasone alone, depending on the patient's previous treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC: L04AX06
-
The drug is prescribed to adults for the treatment of multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC: L04AX06
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with bortezomib and dexamethasone or with dexamethasone alone, depending on the patient's previous treatment experience with other drugs (including lenalidomide).
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC: L04AX06
-
The drug is prescribed for the treatment of hepatocellular carcinoma, advanced renal cell carcinoma, as well as locally advanced or metastatic differentiated thyroid carcinoma that is unresponsive to radioactive iodine therapy.
Dosage form: tablets, film-coated
Active substance Dosage sorafenib 200 mg ATC: L01EX02
-
It is used to treat chronic hepatitis B in adults and adolescents aged 12 years and older (provided that body weight is at least 35 kg).
Dosage form: tablets, film-coated
Active substance Dosage tenofovir alafenamide 25 mg ATC: J05AF13
-
The drug is intended for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Dosage form: tablets, film-coated
Active substance Dosage sofosbuvir 400 mg velpatasvir 100 mg ATC: J05AP55